Minister for Industry and Innovation and Manufacturing Sovereignty Ben Carroll today announced Victorian Government support for Ego Pharmaceuticals’ $35 million investment to increase production capacity by 50 per cent and create 90 new jobs.
The project will add new cream and filling lines to Ego’s Braeside manufacturing facility and extend its distribution centre in Dandenong South, increasing capability and capacity to support local and fast-growing export markets.
The company produces more than 150 dermatological skincare products for local and international markets, with its brands including QV, SunSense, Elucent and Aqium.
From humble beginnings 70 years ago in a laundry in suburban Melbourne, Ego Pharmaceuticals has grown into a leading global brand with more than 730 employees in 15 countries, including around 400 employees in Victoria.
Ego Pharmaceuticals’ products are stocked in more than 20 countries, and exports across Asia, the Middle East and the United Kingdom now make up half its business.
From its sunscreen products to hand sanitiser and gentle skin lotions, Ego Pharmaceuticals has manufactured all its products in Victoria for 70 years. This expansion ensures its manufacturing growth continues onshore, while also securing its supply chain for future development.
“Keeping our high-technology manufacturing in Australia has and always will be important to us,” said Ego Pharmaceuticals’ Managing Director, Mr Alan Oppenheim.
“This Victorian Government grant will help us further in creating good jobs to support our local economy as we continue to grow. It will enable Ego to transform more lives through the science of healthy skin across many nations.”